Crossmark

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Crossref DOI link: https://doi.org/10.1186/s12974-016-0718-0

Published Online: 2016-10-28

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Jarius, Sven

Ruprecht, Klemens

Kleiter, Ingo

Borisow, Nadja

Asgari, Nasrin

Pitarokoili, Kalliopi

Pache, Florence

Stich, Oliver

Beume, Lena-Alexandra

Hümmert, Martin W.

Ringelstein, Marius

Trebst, Corinna

Winkelmann, Alexander

Schwarz, Alexander

Buttmann, Mathias

Zimmermann, Hanna

Kuchling, Joseph

Franciotta, Diego

Capobianco, Marco

Siebert, Eberhard

Lukas, Carsten

Korporal-Kuhnke, Mirjam

Haas, Jürgen

Fechner, Kai

Brandt, Alexander U.

Schanda, Kathrin

Aktas, Orhan

Paul, Friedemann

Reindl, Markus

Wildemann, Brigitte
Funding

Funding for this research was provided by:

Dietmar Hopp Stiftung

Merck Serono

Bundesministerium für Bildung und Forschung (DE) (Competence Network Multiple Sclerosis)

Bundesministerium für Bildung und Forschung (DE) (Competence Network Multiple Sclerosis)

Bundesministerium für Bildung und Forschung (DE) (Competence Network Multiple Sclerosis)

Deutsche Forschungsgemeinschaft (DE) (DFG EXC 257)

European Research Area (E-RARE-2)

Bundesministerium für Wissenschaft, Forschung und Wirtschaft (AT) (Big Wig MS)

Austrian Science Fund (FWF project I916)

Document is current

Any future updates will be listed below